NASDAQ:PULM Pulmatrix (PULM) Stock Price, News & Analysis $1.42 +0.08 (+5.97%) Closing price 04:00 PM EasternExtended Trading$1.37 -0.05 (-3.73%) As of 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsNews and TrendsOwnershipSEC Filings About Pulmatrix Stock (NASDAQ:PULM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Pulmatrix alerts:Sign Up Key Stats Today's Range$1.28▼$1.5250-Day Range$1.28▼$1.7052-Week Range$1.06▼$4.94Volume170,226 shsAverage Volume39,980 shsMarket Capitalization$5.18 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Pulmatrix, Inc. is a clinical-stage biopharmaceutical company developing inhaled therapies. Its proprietary iSPERSE technology is designed to deliver dry-powder medicines to the lungs, and the company’s work has included treatments for respiratory diseases as well as medicines delivered through the lungs for other conditions. Among its drug candidates, PUR1900 is an inhaled formulation of itraconazole being developed for allergic bronchopulmonary aspergillosis, a lung condition associated with fungal sensitivity. PUR3100 is an inhaled formulation of dihydroergotamine being studied as a potential treatment for acute migraine. Founded in 2003, Pulmatrix is based in the United States. Its candidates are in clinical development, and the company’s activities focus on research and development rather than marketing approved medicines.AI Generated. May Contain Errors. Read More Pulmatrix Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks24th Percentile Overall ScorePULM MarketRank™: 1.179920883915 of 5 starsPulmatrix scored higher than 24% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingPulmatrix has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoveragePulmatrix has only been the subject of 1 research reports in the past 90 days.Read more about Pulmatrix's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Pulmatrix is -1.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Pulmatrix is -1.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPulmatrix has a P/B Ratio of 0.58. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.09% of the float of Pulmatrix has been sold short.Short Interest Ratio / Days to CoverPulmatrix has a short interest ratio ("days to cover") of 1.32, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Pulmatrix has recently decreased by 8.50%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPulmatrix does not currently pay a dividend.Dividend GrowthPulmatrix does not have a long track record of dividend growth. News and Social Media3.5 / 5News Sentiment0.59 News SentimentPulmatrix has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Pulmatrix this week, compared to 1 article on an average week.MarketBeat Follows1 people have added Pulmatrix to their MarketBeat watchlist in the last 30 days. Company Ownership0.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Pulmatrix insiders have not sold or bought any company stock.Percentage Held by Insiders0.62% of the stock of Pulmatrix is held by insiders.Percentage Held by Institutions11.84% of the stock of Pulmatrix is held by institutions.Read more about Pulmatrix's insider trading history. Receive PULM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pulmatrix and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PULM Stock News HeadlinesPulmatrix Q3 Loss Widens; Expects Eos SENOLYTIX Merger To Close In November; Stock UpNovember 18 at 9:59 AM | rttnews.comPulmatrix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 17 at 1:30 PM | marketscreener.comMChase, Wells Fargo and Capital One all showed errors on Nov. 16On November 16, customers of Chase, Bank of America, Wells Fargo, Capital One and Zelle reported errors when trying to reach their money. The outage lasted hours. Cedar Gold Group points out that physical gold has no login, no server and needs no one's permission. Its free Wealth Protection Playbook shows how to keep part of your savings outside the banking system.November 19 at 1:00 AM | Cedar Gold Group (Ad)Pulmatrix Announces Third Quarter 2026 Financial Results and Progress on MergerNovember 17 at 8:05 AM | prnewswire.comEos SENOLYTIX's PTC-2105 Reduced Semaglutide-Associated Lean-Mass Loss in Aged Mice: Data to Be Presented at 19th Sarcopenia, Cachexia & Wasting Disorders International ConferenceNovember 9, 2026 | globenewswire.comEos SENOLYTIX Reports Preserved Motor Function In Aged Rats With PTC-2105; Stock DownOctober 30, 2026 | rttnews.comEos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat StudyOctober 30, 2026 | globenewswire.comPulmatrix, Inc. stockholders approve merger-related proposals and reverse stock splitOctober 27, 2026 | msn.comSee More Headlines PULM Stock Analysis - Frequently Asked Questions How have PULM shares performed this year? Pulmatrix's stock was trading at $2.23 at the start of the year. Since then, PULM stock has decreased by 36.1% and is now trading at $1.4250. How were Pulmatrix's earnings last quarter? Pulmatrix, Inc. (NASDAQ:PULM) announced its earnings results on Tuesday, November, 17th. The biotechnology company reported ($0.34) EPS for the quarter, topping analysts' consensus estimates of ($2.00) by $1.66. When did Pulmatrix's stock split? Pulmatrix's stock reverse split on the morning of Tuesday, March 1st 2022.The 1-20 reverse split was announced on Tuesday, March 1st 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, March 1st 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. When did Pulmatrix IPO? Pulmatrix (PULM) raised $22 million in an initial public offering on Wednesday, March 19th 2014. The company issued 2,650,000 shares at a price of $7.25-$9.25 per share. How do I buy shares of Pulmatrix? Shares of PULM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Pulmatrix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pulmatrix investors own include Assertio (ASRT), Ford Motor (F), Atossa Genetics (ATOS), Bionano Genomics (BNGO), Citius Pharmaceuticals (CTXR), 9 Meters Biopharma (NMTR) and Palantir Technologies (PLTR). Company Calendar Last Earnings11/17/2026Today11/19/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (15m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 PULM's financial health is in the Red zone, according to TradeSmith. PULM has been in this zone for over 15 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:PULM CIK1574235 Webwww.pulmatrix.com Phone(781) 357-2333Fax707-525-9906Employees2Year Founded2003Profitability EPS (Trailing Twelve Months)($1.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$5.16 million Net MarginsN/A Pretax MarginN/A Return on Equity-163.02% Return on Assets-110.34% Debt Debt-to-Equity RatioN/A Current Ratio4.70 Quick Ratio4.70 Sales & Book Value Annual Sales$7.81 million Price / Sales0.67 Cash FlowN/A Price / Cash FlowN/A Book Value$2.45 per share Price / Book0.58Miscellaneous Outstanding Shares3,650,000Free Float3,629,000Market Cap$5.20 million OptionableNot Optionable Beta1.95 Social Links 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (NASDAQ:PULM) was last updated on 11/19/2026 by MarketBeat.com Staff. From Our PartnersChase, Wells Fargo and Capital One all showed errors on Nov. 16On November 16, customers of Chase, Bank of America, Wells Fargo, Capital One and Zelle reported errors when t...Cedar Gold Group | SponsoredTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulmatrix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulmatrix With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.